Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Fourth Quarter and Full Year 2020 Coherus BioSciences Conference Call. [Operator Instructions]
I would now like to turn the conference over to your host today, Mr. McDavid Stilwell. Sir, please go ahead.
McDavid Stilwell
Executive Vice President, Corporate Development, Investor Relations, and Financial Strategy
Thank you. Good afternoon, everyone, and thank you for joining us. We issued a press release earlier announcing our 2020 fiscal year and fourth quarter results and the release can be found on the Coherus BioSciences website. Today s call includes forward-looking statements regarding Coherus current expectations. These statements include, but are not limited to, our ability to advance our biosimilar and immuno-oncology product candidates through development and registration.